Johannes Gutenberg University Mainz (JGU) sees itself as an integral part of society with which it works closely and openly; it perceives knowledge transfer as one of its primary objectives. JGU received national recognition for its transfer activities thanks to the success of the Mainz Research Alliance while competing for the 2011 "City of Science" title. In 2017, the university successfully underwent an audit by the Stifterverband; as a result JGU plans to extend its knowledge transfer activities and to align them with a strategic focus.
The transformation of research results into actual applications that can be employed by businesses and administrations and, vice versa, the transposition of experience and new demands from the world of practice to the level of research are fundamental aspects of knowledge transfer at JGU. Important JGU partners include BASF, Boehringer Ingelheim, Merck, and Schott. Companies such as Biontech, Ganymed (recently aquired by Astellas Pharma), StarSEQ, and TRON are successful JGU spin-offs, to name just a few.
The Technology Transfer Office at JGU provides active support during the course of these processes and acts as interface between science and business. It is the central point of contact between companies and the university.
The Startup Center of JGU, which is part of the joint Mainz Office of Entrepreneurship (Hochschulübergreifendes Gründungsbüro), facilitates the establishment of spin-offs. In addition, JGU participates in the pilot phase of Young Entrepreneurs in Science (YES), a continuing education program established by the Falling Walls Foundation.